anemia

Incyte scraps anemia program after drug fails to improve symptoms in rare blood cancer
Fierce Biotech
Sun, 12/15/24 - 10:46 pm
Incyte
myelofibrosis
anemia
zilurgisertib
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure
Fierce Pharma
Tue, 02/27/24 - 11:16 am
AstraZeneca
FibroGen
roxadustat
anemia
Incyte whittles down pipeline, scrapping 6 R&D programs
Fierce Biotech
Tue, 05/2/23 - 11:25 pm
Incyte
R7D
anemia
cancer
FDA Accepts sBLA of BMS' Reblozyl
Targeted Oncology
Mon, 05/1/23 - 10:01 pm
Bristol Myers Squibb
Reblozyl
FDA
MDS
anemia
Genexine's anemia drug matches Roche-CSL product in phase 3, laying groundwork for Asia filings
Fierce Biotech
Tue, 04/11/23 - 10:07 am
Genexine
chronic kidney disease
anemia
Roche
CSL Vifor
Mircera
Docs likely to be 'cautious' when prescribing GSK's first-in-class anemia drug Jesduvroq, survey finds
Fierce Pharma
Thu, 02/9/23 - 06:05 pm
GSK
physicians
anemia
Jesduvroq
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections
Fierce Pharma
Thu, 02/2/23 - 10:28 am
GSK
FDA
daprodustat
Jesduvroq
anemia
chronic kidney disease
AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit
Fierce Pharma
Mon, 12/5/22 - 10:46 pm
FibroGen
trade secrets
anemia
As GSK gears up for high-stakes daprodustat panel review, FDA flags some safety concerns
Fierce Pharma
Wed, 10/26/22 - 10:26 am
GSK
anemia
daprodustat
FDA
Akebia Regains Rights to Anemia Drug After Otsuka Partnership Dissolves
BioSpace
Mon, 07/4/22 - 11:56 pm
Otsuka
Akebia
vadadustat
anemia
As Sanofi prunes pipeline, ex-Alexion crew at Rallybio picks up anemia drug
Endpoints
Tue, 05/10/22 - 10:56 am
Sanofi
Rallybio
KY1066
RLYB331
Kymab
anemia
GSK goes for gold as FDA starts review of daprodustat
Pharmaforum
Tue, 04/19/22 - 10:47 am
GSK
chronic kidney disease
anemia
daprodustat
FDA
FDA rejects Akebia drug, dealing another blow to anemia pills
BioPharma Dive
Thu, 03/31/22 - 10:24 am
Akebia Therapeutics
vadadustat
FDA
chronic kidney disease
anemia
Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms
Endpoints
Thu, 02/24/22 - 09:30 am
Akebia
Vifor
anemia
vadadustat
Agios strategy shift pays off with FDA approval of first drug for rare anemia
MedCity News
Mon, 02/21/22 - 10:28 am
Agios Pharmaceuticals
FDA
pyruvate kinase deficiency
anemia
mitapivat
Agios wins FDA approval for drug to treat rare form of anemia
Stat
Thu, 02/17/22 - 11:16 pm
Agios
mitapivat
pyruvate kinase deficiency
anemia
FDA
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting
Fierce Pharma
Wed, 11/10/21 - 10:42 am
FibroGen
AstraZeneca
anemia
roxadustat
FDA
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
Fierce Biotech
Mon, 11/8/21 - 10:47 am
GSK
chronic kidney disease
cliincal trials
FDA
AstraZeneca
anemia
erythropoietin
FibroGen
FibroGen, fresh off data manipulation scandal, touts win in cancer patients without revealing data
Endpoints
Wed, 08/25/21 - 11:20 am
FibroGen
roxadustat
cancer
anemia
clinical trials
data manipulation
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
Pharmaforum
Fri, 08/20/21 - 10:51 am
Europe
FibroGen
Astellas
Evrenzo
anemia
chronic kidney disease

Pages